Galectin-1

Galectin-1 詳細

英語名Galectin-1市販薬剤の数1
治験薬の数1ターゲットの別称Epididymis Secretory Sperm Binding Protein,Lectin, Galactoside-Binding, Soluble, 1,Beta-Galactoside-Binding Lectin L-14-I,14 KDa Laminin-Binding Protein,S-Lac Lectin 1,14 KDa Lectin,Galaptin,HLBP14,Gal-1,HPL,Beta-Galactoside-Binding Protein 14kDa,Lectin Galactoside-Binding Soluble 1,GAL1,GBP,Galectin 1,Putative MAPK-activating protein PM12,Galectin-1,HBL,LGALS1,Lactose-binding lectin 1
研究&開発段階Approved
英語名Galectin-1
ターゲットの別称Epididymis Secretory Sperm Binding Protein,Lectin, Galactoside-Binding, Soluble, 1,Beta-Galactoside-Binding Lectin L-14-I,14 KDa Laminin-Binding Protein,S-Lac Lectin 1,14 KDa Lectin,Galaptin,HLBP14,Gal-1,HPL,Beta-Galactoside-Binding Protein 14kDa,Lectin Galactoside-Binding Soluble 1,GAL1,GBP,Galectin 1,Putative MAPK-activating protein PM12,Galectin-1,HBL,LGALS1,Lactose-binding lectin 1
市販薬剤の数1
治験薬の数1
研究&開発段階Approved

Galectin-1 製品リスト

  • 属性

    Protein (1)

  • 製品ライブラリ

    オンライン (1)

  • Human (1)

  • タグ

    Tag Free (1)

  • マーカー

    Unconjugated (1)

製品番号発現システム製品説明タンパク質の構造純度特性
GA1-H4113
Human
E. coli
Human Galectin-1 / LGALS1 Protein, Tag Free, low endotoxin (MALS verified)
総数量1
  • 1

Galectin-1バックグランド

Galectin-1 (Gal-1), a member of the β-galactoside-binding animal lectin family, has a wide range of biological activities, which makes it an attractive target for medical applications. Gal-1 is ubiquitously but differentially expressed in normal and pathological animal tissues, and a variety of biological activities, including modulation of innate and adaptive immune responses, malignant progression of tumor cells, etc.

Galectin-1分子の別称

LGALS1,GAL1,GBP,Galectin-1,DKFZp686E23103

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
OlitigaltinGB-0139; TD-139Phase 2 ClinicalLund University Foundation, The University Of EdinburghCoronavirus Disease 2019 (COVID-19); Idiopathic Pulmonary Fibrosis
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
OcriplasminA-01016; THR-409ApprovedThrombogenicsJetrea, JejetreaUnited StatesVitreomacular AdhesionThrombogenics Inc2012-10-17Arterial Occlusive Diseases; Diabetic macular oedema; Diabetic Retinopathy; Disease Progression; Eye Diseases; Macular Degeneration; Retinal Diseases; Retinal Vein Occlusion; Stroke; Uveitis; Venous Thrombosis; Vitreomacular Adhesion; Vitreous Detachment
詳細

レビュー

  • L***h2021-12-13
    0評価
    Dear Sir or Madam, I had an overall good service from Acro Biosystems. Shipment was fast and product quality was good. Got the protocol for QC after asking the customer service. Protocol for QC was easy to understand and repeat. Easy way to download the Certificate of Analysis via the printed QR code on product vials. Customer service answered very fast and was very friendly. QC of Human Galectin-1 protein vs. biotinylated human CD45 protein (CD5-H82E7) was fine.
  • 詳細
  • 製品リスト
  • 市販薬剤に関する情報
  • レビュー
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8